Tuna peptides sales will grow through 2036, led by powder at 60% of the product segment in 2026 on demand for shelf-stable peptide formats. The market was valued at USD 0.97 million in 2025 and is expected to be worth USD 1.63 million by 2036, creating an incremental opportunity of USD 0.61 million.